Why Dyax Corp. Dropped in September

Despite releasing some good news, shares of this biotech fell during the month.

Brian Feroldi
Brian Feroldi
Oct 11, 2015 at 7:03AM
Health Care

Shares of Dyax Corp. (UNKNOWN:DYAX.DL), a biopharma company focused on developing treatments for rare blood disorders, fell more than 13% during September.

Given the share price weakness, is now a good time to considering making an investment in Dyax? See below for my take.